Common Contracts
2 similar Officer Indemnification Agreement contracts by Kiromic Biopharma, Inc.
OFFICER INDEMNIFICATION AGREEMENTOfficer Indemnification Agreement • February 16th, 2022 • Kiromic Biopharma, Inc. • Biological products, (no disgnostic substances) • Delaware
This INDEMNIFICATION AGREEMENT (“Agreement”) is made as of February 14, 2022 by and between Kiromic Biopharma, Inc., a Delaware corporation (the “Company”), and Dan Clark (“Indemnitee”). This Agreement supersedes and replaces any and all previous agreements between the Company and Indemnitee covering the subject matter of this Agreement, except this Agreement does not affect any prior agreements regarding the subject matter of this Agreement entered into in connection with Indemnitee’s role as a member of the Company’s Board of Directors (collectively, “Director Indemnification Agreements”), which shall remain in full force and effect pursuant to their terms.
OFFICER INDEMNIFICATION AGREEMENTOfficer Indemnification Agreement • February 2nd, 2022 • Kiromic Biopharma, Inc. • Biological products, (no disgnostic substances) • Delaware
This INDEMNIFICATION AGREEMENT (“Agreement”) is made as of January 27, 2022 by and between Kiromic Biopharma, Inc., a Delaware corporation (the “Company”), and Pietro Bersani (“Indemnitee”). This Agreement supersedes and replaces any and all previous agreements between the Company and Indemnitee covering the subject matter of this Agreement, except this Agreement does not affect any prior agreements regarding the subject matter of this Agreement entered into in connection with Indemnitee’s role as a member of the Company’s Board of Directors (collectively, “Director Indemnification Agreements”), which shall remain in full force and effect pursuant to their terms.
